{"title": "Norovirus Vaccine Against Experimental Human GII.4 Virus Illness: A Challenge Study in Healthy Adults", "author": "David I Bernstein; Robert L Atmar; G Marshall Lyon III; John J Treanor; Wilbur H Chen; Xi Jiang; Jan Vinje; Nicole Gregoricus; Robert W Frenck; Christine L Moe; Mohamed S Al-Ibrahim; Jill Barrett; Jennifer Ferreira; Mary K Estes; David Y Graham; Robert Goodwin; Astrid Borkowski; Ralf Clemens; Paul M Mendelman", "url": null, "hostname": null, "description": null, "sitename": "Journal of Infectious Diseases", "date": "2015-03-15", "cleaned_text": "605 Views | 402 Downloads Correspondence: David I. Bernstein, MD, Cincinnati Ave, Cincinnati, OH 45229 ( [david.bernstein@cchmc.org](mailto:david.bernstein@cchmc.org)) Acknowledgments: We thank the staff at each of the clinical sites for recruiting and providing care for the study participants; the clinical and laboratory personnel who supported this study (Cincinnati Children's Hospital: Susan Parker, Michele Dickey, Colleen Fitzpatrick, Christina Quigley, Pengwei Huang and Ming Xia; Emory University School of Medicine and Rollins School of Public Health: Dr Amy Kirby and Ashleigh Streby; Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center: Antone R. Opekun, Jocelyn Uriostegui, and Frederick H. Neill; University of Rochester Medical Center: Carolyn Nolan, Doreen Francis, and Diane O'Brien; and Shin Nippon Biomedical Laboratories: Cynthia Yashinski and Will Leslie); the members of the Safety Monitoring Committee (Drs Nancy Browning and Robert B. Belshe); staff at EMMES for their help with statistics, data management, and analysis (Mark Wolff, Tom Greene, and Kelly Schlessman); Julie Cordova and Robin Mertens for their excellent operational expertise; Drs Robert Bargatze and Charles Richardson of Takeda Vaccines, Inc. and Dr Frank Baehner of Takeda Pharmaceuticals International for review and encouragement; and Keith Veitch for editorial assistance. Disclaimer. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. Potential conflicts of interest. R. G., A. B., R. C, and P. M. M. are all full-time employees of the study sponsor; M. K. E. is a named inventor on patents related to cloning of the Norwalk virus genome and is a consultant to Takeda Vaccines (Montana) Inc; and D. I. B. and M. K. E. are consultants to Takeda. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. Financial support: This work was entirely supported by Takeda Vaccines, Inc. \u00a9 The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. "}